[Mode of action of proteinase inhibitors (Trasylol) in intracranial hemorrhages].
D000328:Adult; D000818:Animals; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D007611:Aprotinin / Q000627:therapeutic use*; D002543:Cerebral Hemorrhage / Q000188:drug therapy*; D002648:Child; D006408:Hematoma, Subdural / Q000188:drug therapy; D006801:Humans; D007223:Infant; D007705:Kinins / Q000037:antagonists & inhibitors / Q000502:physiology; D008297:Male; D011480:Protease Inhibitors; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy
D000933:Antifibrinolytic Agents; D007705:Kinins; D011480:Protease Inhibitors; D007611:Aprotinin
Le mode d'action des inhibiteurs de protéinases (Trasylol) dans les hémorragies intra-crâniennes.